Webinar: Accelerating Development of COVID-19 Vaccines Using InDevR's Novel VaxArray Coronavirus SeroAssay We Invite you to our free webinar on June 30th to learn about our new VaxArray Coronavirus SeroAssay ... Read More
InDevR Delivers Commercial Multiplex Coronavirus SeroAssay Kit and Testing Services for Vaccine DevelopmentBoulder, CO – June 17, 2020– InDevR, Inc., a leader in novel analytical technologies that support the ... Read More
InDevR Ships First Multiplexed COVID-19 Serology Test Kits for Clinical ValidationBoulder, CO-9 April 2020– InDevR, Inc., a leader in progressive analytical technologies to support the development and production of ... Read More
InDevR Raises $7 million in Series A Financing with Adjuvant CapitalBoulder, CO, 10 September 2019 – InDevR, Inc., a biotechnology company focused on developing and commercializing novel analytical technologies ... Read More
Clinical validation of the FluChip-8G Influenza A+B Assay for influenza type and subtype identification published in Journal of Clinical Virology Go to Abstract ... Read More
Analytical Evaluation of the Microarray-Based FluChip-8G Influenza A+B Assay published in Journal of Virological Methods Go to Abstract ... Read More
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.